[1]
J. Llerena-Velastegui, “Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular and Renal Outcomes in Heart Failure Patients With Type 2 Diabetes: A Literature Review”, J Clin Med Res, vol. 16, no. 9, pp. 398–410, Sep. 2024, doi: 10.14740/jocmr5230.